Translational Medicine Research Collaboration (TMRC)


At a Glance
  • Status: Completed Consortium
  • Year Launched: 2006
  • Initiating Organization: BioDundee
  • Initiator Type: Government
  • No disease focus
  • Location: Europe

Abstract

The Translational Medicine Research Collaboration focuses on developing novel tests for the diagnosis and monitoring of diseases such as cancer, heart disease, and depression using biomarkers.

Mission

The Collaboration will involve efforts to facilitate the rapid transfer of new drugs and other treatments from the laboratory into the clinic, as well as pharmacogenetics, to identify good and poor responders to specific drugs to enable clinicians to use the safest and most effective drug for a given patient and condition. The Collaboration will consist of a central core research laboratory (based at the University of Dundee) linked to centers of excellence in each of the four university medical schools for clinical research. The initiative also builds on the development of a new Clinical Research Centre network across the four universities and the NHS regions. The Scottish Enterprise funding will be used to set up a new company to act as a link between the participating organizations.

Consortium History

2006:  Collaboration established

Financing

The Translational Medicine Research Collaboration is funded by Wyeth (around €33 million over five years) and Scottish Enterprise (up to €17.5 million).

Sponsors & Partners

Aberdeen University

Dundee University

Edinburgh University

Glasgow University

NHS Scotland

Wyeth Pharmaceutical


Last Updated: 04/07/2016

The Consortia-pedia Catalogue is a living resource, and we are always adding new consortia. Provide information here about your collaboration to apply to be included in the Catalogue.

All the information contained in the Consortia-pedia was collected from publically available sources. Decisions to include or exclude a particular listing from Consortia-pedia were also made on the basis of publically available information and the criteria outlined in the FAQs. This site is intended to be an objective resource for the community, and inclusion does not constitute or imply endorsement, recommendation, or approval by FasterCures or the Milken Institute.